Physician-initiated Medication Review in a Type 2 Diabetes Outpatient Clinic

NCT05501223 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-08-15

No results posted yet for this study

Summary

Aiming to reduce polypharmacy in patients with type 2 diabetes by using physician-initiated medication reviews.

Conditions

  • Polypharmacy

Interventions

OTHER

Medication review

30-60 minutes extra consultation regarding the patients drugs

OTHER

Standard care

Standard care i.e. visit at the Dept. of Endocrinology.

Sponsors & Collaborators

  • Bispebjerg Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2022-11-30
Completion
2022-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05501223 on ClinicalTrials.gov